Blog - Page 3 of 11 - Patient Focused Medicines Development
How patients’ voices can change drug approval

Consulting patients early and often can help regulators understand how medicines users view risk, benefit and quality of life The case of Lotronex (alosteron), a medicine for the management of severe irritable bowel syndrome (IBS), illustrates how patients can work with drug regulators to get the risk-benefit balance right. The story has echoes of Tysabri – a well-known multiple...

Read More